BMO Capital Reiterates Market Perform on Casey's General Stores (CASY) Following 2Q Report
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Jefferies Raises Price Target on Casey's General Stores (CASY) Following 2Q Earnings Report
December 9, 2016 7:06 AM ESTJefferies reiterated a Buy rating on Casey's General Stores (NASDAQ: CASY), and raised the price target to $143.00 (from $128.00), following the company's 2Q earnings report. CASY reported adjusted EPS of $1.45, compared to the consensus of $1.59. EBITDA of $149M missed the consensus estimate of $154M.
Analyst... More
After-Hours Stock Movers 12/07: (VYGR) (LULU) (HRB( Higher; (OHRP) (VRNT) (CMTL) Lower (more...)
December 7, 2016 7:04 PM ESTToday's After-Hours Movers:
Voyager Therapeutics, Inc. (Nasdaq: VYGR) 35.2% HIGHER; announced positive results from the ongoing Phase 1b trial of VY-AADC01 at six and twelve months of follow-up in patients with advanced Parkinsons disease. The interim data from Cohorts 1 and 2 of this trial demonstrated that accurate MRI-guided delivery of escalating doses of VY-AADC01 were well tolerated and resulted in increased coverage of the putamen, increased AADC enzyme activity, enhanced response to levodopa, and dose-related, clinically meaningful improvements in various measures of patients motor function. This was... More
Casey's General Stores (CASY) Misses Q2 EPS by 15c
December 7, 2016 4:42 PM ESTCasey's General Stores (NASDAQ: CASY) reported Q2 EPS of $1.44, $0.15 worse than the analyst estimate of $1.59. Revenue for the quarter came in at $1.92 billion versus the consensus estimate of $1.94 billion.
For the quarter, same-store gallons sold were up 3.7% with an average margin above... More
